135 related articles for article (PubMed ID: 37823896)
1. RNAseq-based transcriptomics of treatment-naïve multi-inflammatory syndrome in children (MIS-C) demonstrates predominant activation of matrisome, innate and humoral immune pathways.
Patnaik S; Mruthyunjaya P; Murmu KC; Mahapatra S; Patro ARK; Misra R; Pati S; Prasad P; Ahmed S
Rheumatol Int; 2023 Oct; ():. PubMed ID: 37823896
[TBL] [Abstract][Full Text] [Related]
2. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
[TBL] [Abstract][Full Text] [Related]
3. Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children.
Boyarchuk O; Kovalchuk T
Reumatologia; 2023; 61(1):63-70. PubMed ID: 36998579
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
Rodriguez-Smith JJ; Verweyen EL; Clay GM; Esteban YM; de Loizaga SR; Baker EJ; Do T; Dhakal S; Lang SM; Grom AA; Grier D; Schulert GS
Lancet Rheumatol; 2021 Aug; 3(8):e574-e584. PubMed ID: 34124694
[TBL] [Abstract][Full Text] [Related]
5. Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease.
Netea SA; Biesbroek G; van Stijn D; Ijspeert H; van der Made CI; Jansen MH; Geissler J; van den Berg JMM; van der Kuip M; Gruppen MP; Schonenberg-Meinema D; Kapitein B; van Furth AMMT; Nagelkerke SQ; Pajkrt D; Plötz FB; den Boer MEJL; Landman GW; van Houten MA; Goetschalckx I; ; Toonen EJM; van de Veerdonk FL; Kuipers IM; Dik WA; Kuijpers TW
EBioMedicine; 2023 Sep; 95():104736. PubMed ID: 37524002
[TBL] [Abstract][Full Text] [Related]
6. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C.
Zhu YP; Shamie I; Lee JC; Nowell CJ; Peng W; Angulo S; Le LN; Liu Y; Miao H; Xiong H; Pena CJ; Moreno E; Griffis E; Labou SG; Franco A; Broderick L; Hoffman HM; Shimizu C; Lewis NE; Kanegaye JT; Tremoulet AH; Burns JC; Croker BA;
J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34464357
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
Front Immunol; 2018; 9():2995. PubMed ID: 30619348
[No Abstract] [Full Text] [Related]
8. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.
Pfeifer J; Thurner B; Kessel C; Fadle N; Kheiroddin P; Regitz E; Hoffmann MC; Kos IA; Preuss KD; Fischer Y; Roemer K; Lohse S; Heyne K; Detemple MC; Fedlmeier M; Juenger H; Sauer H; Meyer S; Rohrer T; Wittkowski H; Becker SL; Masjosthusmann K; Bals R; Gerling S; Smola S; Bewarder M; Birk E; Keren A; Böhm M; Jakob A; Abdul-Khaliq H; Anton J; Kabesch M; Pino-Ramirez RM; Foell D; Thurner L
Lancet Rheumatol; 2022 May; 4(5):e329-e337. PubMed ID: 35368387
[TBL] [Abstract][Full Text] [Related]
9. IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort.
Spracklen TF; Mendelsohn SC; Butters C; Facey-Thomas H; Stander R; Abrahams D; Erasmus M; Baguma R; Day J; Scott C; Zühlke LJ; Kassiotis G; Scriba TJ; Webb K
Front Immunol; 2022; 13():992022. PubMed ID: 36148243
[TBL] [Abstract][Full Text] [Related]
10. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
[TBL] [Abstract][Full Text] [Related]
12. Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum.
Go E; van Veenendaal M; Manlhiot C; Schneider R; McCrindle BW; Yeung RSM
Front Pediatr; 2021; 9():665815. PubMed ID: 33996701
[TBL] [Abstract][Full Text] [Related]
13. A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.
Shahbaz FF; Martins RS; Umair A; Ukrani RD; Jabeen K; Sohail MR; Khan E
Clin Med Insights Pediatr; 2022; 16():11795565221075319. PubMed ID: 35197719
[TBL] [Abstract][Full Text] [Related]
14. An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.
Kessel C; Koné-Paut I; Tellier S; Belot A; Masjosthusmann K; Wittkowski H; Fuehner S; Rossi-Semerano L; Dusser P; Marie I; Boukhedouni N; Agostini H; Piedvache C; Foell D
J Clin Immunol; 2022 Aug; 42(6):1330-1341. PubMed ID: 35699824
[TBL] [Abstract][Full Text] [Related]
15. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
[TBL] [Abstract][Full Text] [Related]
16. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang CA; Huang YL; Chiang BL
J Formos Med Assoc; 2022 Mar; 121(3):623-632. PubMed ID: 34193364
[TBL] [Abstract][Full Text] [Related]
17. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review.
Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC
J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.
Ueno K; Nomura Y; Morita Y; Kawano Y
Front Immunol; 2021; 12():640315. PubMed ID: 34079539
[TBL] [Abstract][Full Text] [Related]
19. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
[TBL] [Abstract][Full Text] [Related]
20. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
